
Please try another search
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Name | Age | Since | Title |
---|---|---|---|
Arpit Janmejay Vyas | 39 | 2012 | Global MD & Director |
Deohooti Janmejay Vyas | 74 | 2017 | Whole Time Director |
Hemantkumar J. Bhatt | - | 2025 | Independent Director |
Margie S. Parikh | - | 2025 | Independent Director |
Kulin N. Shah | - | 2024 | Independent Director |
Dhaval R. Shah | - | 2025 | Non-Executive & Non-Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review